Showing results (131-140 of 170) with videos related to

Sort By:
Pageof 17
World Journal of Oncology|September 27, 2024
Patterns and Frequency of Pathogenic Germline Variants Among Prostate Cancer Patients Utilizing Multi-Gene Panel Genetic TestingRamiz Abu Hijlih, Baha Sharaf, Samer Salah, et al.
Frontiers in Genetics|November 3, 2023
Pathogenic germline variants in patients with breast cancer: conversations across generations, practices and patients' attitudeHikmat Abdel-Razeq, Rawan Mustafa, Sarah Abdel-Razeq, et al.
Seminars in Nuclear Medicine|July 4, 2025
[177Lu]Lu-FAPI Radioligand Therapy: Emerging Horizons and Clinical Promise in Solid Tumors: A Comprehensive ReviewAkram Al-Ibraheem, Ahmed Saad Abdlkadir, Saad Ruzzeh, et al.
World Journal of Oncology|September 27, 2024
Multi-Gene Panel Testing for Hereditary Cancer Predisposition Among Patients Sixty-Five Years and Above Diagnosed With Breast CancerHikmat Abdel-Razeq, Faris Tamimi, Baha Sharaf, et al.
Cancers|February 25, 2022
Supportive Care Needs Assessment for Cancer Survivors at a Comprehensive Cancer Center in the Middle East: Mending the GapAmal Al-Omari, Nedal Al-Rawashdeh, Rana Damsees, et al.
Cancers|April 27, 2024
Ocular and Periocular Metastasis in Breast Cancer: Clinical Characteristics, Prognostic Factors and Treatment OutcomeYacoub A Yousef, Mona Mohammad, Hanan Khalil, et al.
Hematology (Amsterdam, Netherlands)|June 18, 2025
Dose adjusted EPOCH-R is superior to RCHOP in frontline treatment of mediastinal large B cell lymphomaMohammad Ma'koseh, Abeer Yaseen, Nebras Abu Abed, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 26, 2025
Outcomes of Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide and Earlier Initiation of ImmunosuppressionMohammad Ma'koseh, Zaid Abdel Rahman, Abeer Yaseen, et al.
Biologics : Targets & Therapy|September 5, 2025
Enhancing Early Detection of Pancreatic Cancer in Genetically Predisposed Individuals: Integrating Advanced Imaging Modalities with Emerging Biomarkers and Liquid BiopsyRashid Abdel-Razeq, Asem Mansour, Maha Barbar, et al.
Biologics : Targets & Therapy|March 11, 2025
Dual Anti-HER2 Therapy Vs Trastuzumab Alone with Neoadjuvant Anthracycline and Taxane in HER2-Positive Early-Stage Breast Cancer: Real-World InsightsBaha Sharaf, Faris Tamimi, Haneen Al-Abdallat, et al.
Pageof 17